Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
InChi: InChI=1S/C13H10N2O/c16-13(12-5-8-14-9-6-12)4-3-11-2-1-7-15-10-11/h1-10H/b4-3+
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
Use of a quantitative proteomics approach confirmed the selectivity of CTx - 0294885 -bound beads for kinase enrichment
Y15 was shown to decrease cancer growth in vitro and in vivo
Smiles: CCC1=C(C2C(=CC=CC=2N1CC1C=CC=CC=1)OCC(O)=O)C(=O)C(N)=O
WAY-100635 - CAS# 162760-96-5 eropenem InChi: InChI=1S/C13H10N2O/c16-13(12-5-8-14-9-6-12)4-3-11-2-1-7-15-10-11/h1-10H/b4-3+WAY 100635 is a piperazine drug and research chemical widely used in scientific studies. It was originally believed to act as a selective 5 HT1A receptor antagonist, but subsequent research showed that it also acts as potent full agonist at the D4 receptor. It is sometimes referred to as a silent antagonist at the former receptor. It is closely related to WAY 100,135. Product information CAS Number: 162760 96 5 Molecular Weight: 422. 56 Formula:
US$ 1603.50
US$ 382.00
US$ 376.00
US$ 510.00
US$ 418.00
US$ 523.50
US$ 2906.00
US$ 418.00
US$ 510.00
US$ 510.00
US$ 382.00
US$ 1651.50
US$ 618.00
US$ 1479.50
US$ 618.00
US$ 675.00
US$ 857.00